Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Newtown, New South Wales-based Genetic Signatures operates in Biotechnology Research. It is publicly held, and its site is geneticsignatures.com. It holds one address on record, all in Australia. Headcount on record is 98. Its work is tagged molecular Diagnostics, infectious Disease Detection and real-Time PCR. One Australian registration (ABN) is a confirmed match. It is listed alongside eight similar brands, mostly in Biotechnology Research.
geneticsignatures.com LinkedIn
ABN30095913205
| GENETIC SIGNATURES LIMITED | ABN 30095913205 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Genetic Signatures is an established, global molecular diagnostics company, specialising in syndromic multiplex real-time PCR testing to provide configurable, clinically relevant MDx solutions for infectious diseases. A diverse range of assays are available under the EasyScreen™ brand, for the flexible detection of over 100 pathogens impacting global health.
The EasyScreen™ kits are underpinned by Genetic Signatures’ innovative 3base™ technology, which transforms natural genetic sequences into a 3base™ sequence of A, T and C which improves multiplex efficiency and reduces the genetic complexity of detecting pathogens. This is particularly beneficial for detecting pathogen subtypes and providing increased resistance to mutation or variants, such as SARS-CoV-2.
Genetic Signatures’ flexible syndromic approach provides a timely and accurate diagnosis that enhances efficiencies within the laboratory. Customers trust Genetic Signatures’ assay and workflow reliability which is supported by the Company’s high service standards and genuine partnership for driving improved patient outcomes.
Genetic Signatures’ EasyScreen™ products are accessible in over 30 countries, with direct representation in the United States, United Kingdom, Germany, and Australia, and distribution partners in Canada, South America, Africa and other European nations. Products are used for IVD use and research purposes.
As an employer, Genetic Signatures is proud of their highly rated and diverse workplace culture, and is committed to providing equal employment opportunities and professional development.
Visit www.geneticsignatures.com for more information or email marketing@geneticsignatures.com to contact your local specialist.
#moleculardiagnostics #pathology #PCR #multiplex #infectiousdisease #3base
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One New South Wales entity on the ABR: GENETIC SIGNATURES LIMITED (ABN 30 095 913 205), high confidence.
98 counted staff profiles at January 2026, inside the self-reported 51–200 band.
One address on record, Australia only. Primary: 7 Eliza St, Newtown, New South Wales 2042.
None linked to this brand.
Six tags on the brand's own list, among them Molecular Diagnostics, Infectious Disease Detection and Real-Time PCR.
22 profiles list Genetic Signatures as a peer — 94th percentile in Biotechnology Research. It lists ten peers of its own. Syngenis Labs and R-Biopharm Australia list it back.